Litcius/Paper detail

Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study

Yoko Edahiro, Kohshi Ohishi, Akihiko Gotoh, Katsuto Takenaka, Hirohiko Shibayama, Takayuki Shimizu, Kensuke Usuki, Kazuya Shimoda, Masafumi Ito, Scott A. VanWart, Oleh Zagrijtschuk, Albert Qin, Hiroaki Kawase, Narihisa Miyachi, Toshiaki Sato, Norio Komatsu, Keita Kirito

2022International Journal of Hematology37 citationsDOI

Topics & Concepts

MedicinePolycythemia veraAdverse effectInternal medicinePhlebotomyInterferon alfaClinical trialHematologySurgeryGastroenterologyCancerImmunotherapyMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesKruppel-like factors research
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study | Litcius